Clinical Trials Browser

Recruiting × Leukemia, Lymphoid × blinatumomab × Clear all

NCT06111625 2023-11-01

Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALL

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Lymphoid